Bauro, Myrel B.
HRN: 25-27-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2024
CIPROFLOXACIN 500MG (TAB)
06/19/2024
06/26/2024
PO
500mg
Q12
Complicated UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes